The General Session Government Affairs Roundtable, Tuesday, March 25, at 9 to 10:30 a.m., in the Grand Saguaro East/West, is a must-see presentation. IWLA Washington Representative Pat O’Connor will start […]
The U.S. Food and Drug Administration had a busy week. First, the FDA issued its 10-year implementation plan for the Drug Supply Chain Security Act. This includes estimated timeframes and […]
The U.S. National Labor Relations Board (NLRB) re-issued regulations governing representation-case procedures under its National Labor Relations Act, which were first proposed in June 2011. Representation-case procedures, also known as […]
At the request of the U.S. Food and Drug Administration IWLA recently debriefed more than 30 FDA attorneys, economists and compliance specialists on the distinguishing factors between third-party logistics providers […]
The International Warehouse Logistics Association (IWLA) is following implementation of the Drug Quality and Security Act (DQSA) closely. The DQSA was signed into law on Nov. 27, 2013. According to […]
Under the Drug Quality and Security Act, 3PLs will required to comply with national licensing standards (and/or potentially state licensing standards) including: Establish a process for third-party accreditation; provide for periodic inspection; prohibit a facility from […]
Members of the U.S. Congress went home at the end of 2013 without extending several key tax incentives, two of which may have an impact on your warehousing facility: One […]
The IWLA Chemical Council found its footing in 2013. The group is positioned for growth and success in the new year. “The biggest accomplishment in 2013 was the acceptance of […]
Nearly three-dozen IWLA-member companies are dues-paying participants in the IWLA Rail Council. These rail-served warehousing organizations play an active role in shaping how the industry works with railroads. For example, […]
In general, International Warehouse Logistics Association member companies support regulations such as the U.S. Food and Drug Administration’s (FDA) Good Manufacturing Practice and Hazard Analysis and Risk-based Preventive Controls for […]
iwla1891 